Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2002
11/27/2002EP0777471B1 Inhibition of leukotriene biosynthesis with urea derivatives
11/27/2002EP0776204B1 Indole alkaloids useful as anti-inflammatory agents
11/27/2002EP0708648B1 Inhibition of nitric oxide production by retinoic acid
11/27/2002EP0627933B1 Bystander suppression of autoimmune diseases
11/27/2002CN1382211A Treatment of inflammatory or malignant disease using dnazymes
11/27/2002CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002CN1382142A Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382137A Thtrahydrothiopy 2,3-diazanaphthylaone derivatives as PDE inhibitors
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002CN1382119A Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof
11/27/2002CN1382061A Pharmaceutical compositions for oral and topical administration
11/27/2002CN1382057A Treatment of conjunctivitis
11/27/2002CN1382052A Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
11/27/2002CN1381269A Plaster for treating inflammations and sores
11/27/2002CN1381254A Medicine for treating fiver by nasal application and its preparing process
11/27/2002CN1094936C New flavnoe compounds, process for preparing them and pharmaceutical compositions containing them
11/27/2002CN1094757C Isobutyl gamma-amino-butyric acid and its derivatives for treatment of pain
11/27/2002CN1094755C Controlled release agent containing reamine benzene ring alcohol or it salt
11/26/2002US6486193 Antiarthritic agents; antiinflammatory agents
11/26/2002US6486190 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
11/26/2002US6486186 Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
11/26/2002US6485968 Ectoparasite saliva proteins and apparatus to collect such proteins
11/26/2002US6485755 Methods of using electron active compounds for managing cancer
11/26/2002CA2258285C Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
11/26/2002CA2257142C 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
11/26/2002CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/26/2002CA2078555C Novel vitamin d analogues
11/21/2002WO2002093176A2 Methods for identifying compounds for treatment of ibd
11/21/2002WO2002092808A1 Random gene unidirectional antisense library
11/21/2002WO2002092807A1 Unigene unidirectional antisense library
11/21/2002WO2002092793A1 Method for obtaining antigen-specific tr1 regulatory lymphocytes
11/21/2002WO2002092781A2 Peptide compounds for counteracting reactive oxygen species and free radicals
11/21/2002WO2002092773A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002WO2002092762A2 Cytokine polypeptides
11/21/2002WO2002092759A2 Molecules for disease detection and treatment
11/21/2002WO2002092758A2 Gastrokines and derived peptides including inhibitors
11/21/2002WO2002092616A1 Antisense permeation enhancers
11/21/2002WO2002092597A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002WO2002092596A1 Novel sulfonate substituted pyrazol pyridine dervivatives
11/21/2002WO2002092594A1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002WO2002092593A1 4-(4-pyridazinyl)pyrazole derivatives
11/21/2002WO2002092590A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
11/21/2002WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002WO2002092576A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002WO2002092573A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
11/21/2002WO2002092571A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002WO2002092568A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002WO2002092567A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002WO2002092563A2 Protease inhibitors
11/21/2002WO2002092556A1 Sulfonamide derivatives
11/21/2002WO2002092553A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002WO2002092540A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms
11/21/2002WO2002092136A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002WO2002092119A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
11/21/2002WO2002092094A1 Crystalline isoxazole derivative and medical preparation thereof
11/21/2002WO2002092090A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002WO2002092089A1 Tartrate salts of 5,8,14-triazatetracyclo {10.3.1.0?2,11.04,9¿}-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002WO2002092087A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002WO2002092075A2 Therapeutic delivery of carbon monoxide
11/21/2002WO2002092073A1 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
11/21/2002WO2002092069A1 Permeation enhancers
11/21/2002WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002WO2002092065A2 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
11/21/2002WO2002092064A2 Therapeutic method for inducing tolerance
11/21/2002WO2002092015A2 Reagents and methods for modulating dkk-mediated interactions
11/21/2002WO2002092008A2 Use of il-18 inhibitors for the treatement or prevention of sepsis
11/21/2002WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002WO2002091996A2 Methods for treating cancer
11/21/2002WO2002091993A2 Estrogen receptor modulators
11/21/2002WO2002091990A2 Prevention of addiction in pain management
11/21/2002WO2002078615A3 Antioxidant nitroxides and nitrones as therapeutic agents
11/21/2002WO2002076381A3 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
11/21/2002WO2002074981A3 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
11/21/2002WO2002074784A3 Novel use of a peptide class of compound for treating non neuropathic inflammatory pain
11/21/2002WO2002055098A3 Latency associated peptide for providing latency to pharmaceutically active proteins
11/21/2002WO2002022169A3 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
11/21/2002WO2002018341A9 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
11/21/2002WO2002012250B1 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
11/21/2002WO2002005799A3 Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
11/21/2002WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/21/2002WO2001042273A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/21/2002WO2001030338A8 6-methoxy-2-naphthylacetic acid prodrugs for treating inflammation
11/21/2002WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002US20020173736 Plaster containing 4-biphenylacetic acid
11/21/2002US20020173661 Phosphodiesterase-4 (PDE4); thiazole-containing pyridine (N-oxide) compounds; 4-(2-(3,4-Bis(difluoromethoxy)phenyl)-2-(5-(2-(1-hydroxy-1 -methyl)ethyl)thiazolyl)ethyl)pyridine N-oxide for example
11/21/2002US20020173658 Administering to a mammal a substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines to reduce the levels of tumor necrosis factor-alpha to treat autoimmune diseases
11/21/2002US20020173654 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor, and useful as viricides and antitumor agents
11/21/2002US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them
11/21/2002US20020173540 Using plant extract
11/21/2002US20020173528 Agonists specific for the peripheral cannabinoid receptor
11/21/2002US20020173527 Tumor necrosis factor antagonist; antiinflammatory agents
11/21/2002US20020173521 Inhibitors of copper-containing amine oxidases
11/21/2002US20020173520 Quinoline derivatives
11/21/2002US20020173519 Quinoline derivatives
11/21/2002US20020173515 Antiproliferative agents
11/21/2002US20020173514 Pyridine-substituted pyrazolopyridine derivatives
11/21/2002US20020173510 Nutrient mixture; fatty acid, calcium compound and vitamins
1 ... 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 ... 1272